[Corrigendum] Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation

• Authors:
  • Kou‑Gi Shyu
  • Marappan Velusamy
  • Chih‑Wei Hsia
  • Chih‑Hao Yang
  • Chih‑Hsuan Hsia
  • Duen‑Suey Chou
  • Thanasekaran Jayakumar
  • Joen‑Rong Sheu
  • Jiun‑Yi Li

• View Affiliations

  
  Affiliations: Division of Cardiology, Shin Kong Wu Ho‑Su Memorial Hospital, Taipei 111, Taiwan, R.O.C., Department of Chemistry, North Eastern Hill University, Shillong, Meghalaya 793022, India, Graduate Institute of Medical Sciences and Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan, R.O.C.
• Published online on: April 30, 2019     https://doi.org/10.3892/ijmm.2019.4177
• Pages: 357-357

• Copyright : © Shyu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article